United Therapeutic
(NQ:
UTHR
)
320.99
-2.09 (-0.65%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
878,909
Open
323.73
Bid (Size)
320.73 (1)
Ask (Size)
320.99 (1)
Prev. Close
323.08
Today's Range
316.32 - 323.73
52wk Range
208.62 - 343.98
Shares Outstanding
44,891,523
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
NASDAQ:UTHR is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
August 15, 2024
UNITED THERAPEUTICS CORP (NASDAQ:UTHR) is probably undervalued for the fundamentals it is displaying.
Via
Chartmill
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
August 05, 2024
Via
Benzinga
Performance
YTD
+41.19%
+41.19%
1 Month
-3.15%
-3.15%
3 Month
+17.04%
+17.04%
6 Month
+49.49%
+49.49%
1 Year
+40.71%
+40.71%
More News
Read More
3 Biotech Stocks on Track for 50% Returns (or More) by 2028
August 04, 2024
Via
InvestorPlace
UTHR Stock Earnings: United Therapeutics Misses EPS, Beats Revenue for Q2 2024
July 31, 2024
Via
InvestorPlace
United Therapeutics Stock Skids On Mixed Second-Quarter Results
July 31, 2024
Via
Investor's Business Daily
United Therapeutics Corporation Reports Second Quarter 2024 Financial Results
July 31, 2024
From
United Therapeutics Corporation
Via
Business Wire
Navigating 9 Analyst Ratings For United Therapeutics
July 25, 2024
Via
Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $28,000 Today
July 16, 2024
Via
Benzinga
Unveiling 6 Analyst Insights On United Therapeutics
July 08, 2024
Via
Benzinga
The 3 Best 3D Bioprinting Stocks to Buy Now
July 26, 2024
Via
InvestorPlace
Beam Therapeutics Stock Earns RS Rating Jump To 85
July 24, 2024
Via
Investor's Business Daily
United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024
July 24, 2024
From
United Therapeutics Corporation
Via
Business Wire
Here's How Much $1000 Invested In United Therapeutics 5 Years Ago Would Be Worth Today
July 22, 2024
Via
Benzinga
Biotech Arvinas Stock Earns 82 RS Rating
July 17, 2024
Via
Investor's Business Daily
Don't overlook NASDAQ:UTHR—it's a hidden gem with strong fundamentals and an attractive price tag.
July 17, 2024
Via
Chartmill
Denali Therapeutics Stock Gets Technical Rating Upgrade
July 16, 2024
Via
Investor's Business Daily
3 Biotech Stocks to Buy Now: Q3 Edition
July 15, 2024
Via
InvestorPlace
United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
July 10, 2024
From
United Therapeutics Corporation
Via
Business Wire
3 Undervalued Stocks on Track to Double (or More) by 2028
July 08, 2024
Via
InvestorPlace
Members of Congress Buy and Sell Stocks. These ETFs Let You Invest Like Democrats or Republicans.
July 02, 2024
Via
The Motley Fool
Topics
ETFs
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
July 01, 2024
Via
InvestorPlace
Chart Of The Day: United Therapeutics - Drugs For Chronic Illnesses
June 28, 2024
Via
Talk Markets
UroGen Pharma Stock Earns 91 RS Rating
June 27, 2024
Via
Investor's Business Daily
United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors
June 27, 2024
From
United Therapeutics Corporation
Via
Business Wire
When you look at NASDAQ:UTHR, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
June 26, 2024
Via
Chartmill
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.